Etanercept and Ustekinumab Dosing for Plaque Psoriasis and Psoriatic Arthritis.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 5, p. 150
- By:
- Publication type:
- Article
Works matching IS 19454481 AND DT 2017 AND VI 9 AND IP 5
Results: 6
1
2
Guiding Practices for Patient-Centered Value Assessment.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 5, p. 160
- By:
- Publication type:
- Article
3
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 5, p. 155
- By:
- Publication type:
- Article
4
Biosimilars May Change the Treatment Landscape for Inflammatory Diseases.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding
5
The Path to "Economic Value" in Specialty-Patient Care.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 5, p. 142
- By:
- Publication type:
- Article
6
Compliance and Cost of Biologic Therapies for Rheumatoid Arthritis.
- Published in:
- American Journal of Pharmacy Benefits, 2017, v. 9, n. 5, p. 84
- By:
- Publication type:
- Article